Mettler-Toledo International (NYSE:MTD) Price Target Raised to $1,400.00

Mettler-Toledo International (NYSE:MTD) had its price target increased by Wells Fargo & Company from $1,200.00 to $1,400.00 in a research report released on Monday morning,Benzinga reports. The firm currently has an equal weight rating on the medical instruments supplier’s stock.

A number of other equities analysts have also recently commented on MTD. Stifel Nicolaus lifted their price target on Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the stock a “buy” rating in a report on Monday. JPMorgan Chase & Co. lifted their target price on Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the stock a “neutral” rating in a research note on Thursday, October 9th. Evercore ISI increased their price target on Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the company an “outperform” rating in a research note on Tuesday, October 7th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Mettler-Toledo International in a report on Wednesday, October 8th. Finally, Citigroup upped their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a “buy” rating in a report on Thursday, August 21st. Five research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to MarketBeat.com, Mettler-Toledo International currently has a consensus rating of “Hold” and a consensus price target of $1,406.50.

Mettler-Toledo International Trading Up 0.3%

NYSE:MTD opened at $1,448.86 on Monday. The stock has a market capitalization of $29.85 billion, a PE ratio of 36.69, a P/E/G ratio of 4.19 and a beta of 1.41. Mettler-Toledo International has a 1-year low of $946.69 and a 1-year high of $1,471.07. The firm has a fifty day simple moving average of $1,330.14 and a 200 day simple moving average of $1,244.83.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 EPS for the quarter, beating analysts’ consensus estimates of $10.62 by $0.53. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The firm had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $997.36 million. During the same quarter last year, the company posted $10.21 earnings per share. The company’s revenue for the quarter was up 7.9% compared to the same quarter last year. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. On average, equities analysts predict that Mettler-Toledo International will post 42.71 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Mettler-Toledo International news, CFO Shawn Vadala sold 300 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $1,325.00, for a total transaction of $397,500.00. Following the transaction, the chief financial officer owned 5,095 shares in the company, valued at $6,750,875. This trade represents a 5.56% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.94% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Mettler-Toledo International

Several institutional investors and hedge funds have recently modified their holdings of MTD. Bank of New York Mellon Corp raised its stake in Mettler-Toledo International by 71.3% in the 2nd quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier’s stock worth $1,062,257,000 after purchasing an additional 376,419 shares in the last quarter. Norges Bank acquired a new position in shares of Mettler-Toledo International during the 2nd quarter worth approximately $360,126,000. Alliancebernstein L.P. increased its holdings in shares of Mettler-Toledo International by 21.6% during the first quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier’s stock worth $837,653,000 after purchasing an additional 126,147 shares during the period. PineStone Asset Management Inc. raised its position in shares of Mettler-Toledo International by 41.9% in the second quarter. PineStone Asset Management Inc. now owns 334,349 shares of the medical instruments supplier’s stock valued at $392,766,000 after buying an additional 98,737 shares in the last quarter. Finally, Rakuten Investment Management Inc. bought a new stake in shares of Mettler-Toledo International in the third quarter valued at approximately $121,021,000. 95.07% of the stock is currently owned by institutional investors and hedge funds.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.